Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medipal HoldingsMEPDF 81 Equity-to-Asset is 0.34 as of Mar. 2026, which is 10% above its 10-year median of 0.31. GuruFocus rates MEPDF with a GF Score™ of 81/100 and a GF Value™ of $17.73 (Fairly Valued). The stock has 3 warning signs investors should review. Among 120 Medical Distribution companies, Medipal Holdings ranks worse than 61.67% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Medipal Holdings's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $4,110 Mil. Medipal Holdings's Total Assets for the quarter that ended in Mar. 2026 was $12,112 Mil.
Therefore, Medipal Holdings's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.34.
The historical rank and industry rank for Medipal Holdings's Equity-to-Asset or its related term are showing as below:
MEPDF'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.29 Med: 0.31 Max: 0.34
Current: 0.34
During the past 13 years, the highest Equity to Asset Ratio of Medipal Holdings was 0.34. The lowest was 0.29. And the median was 0.31.
MEPDF's Equity-to-Asset is ranked worse than 61.67% of 120
companies
in the Medical Distribution industry
Industry Median: 0.39
vs MEPDF: 0.34
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Medipal Holdings Equity-to-Asset Related Terms
Medipal Holdings Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Medipal Holdings's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEPDF vs MCK, COR, CAH: Equity-to-Asset Comparison
For the Medical Distribution subindustry, Medipal Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medipal Holdings Equity-to-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medipal Holdings's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Medipal Holdings's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Medipal Holdings's Equity to Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medipal Holdings (MEPDF) has a Equity-to-Asset of 0.34 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Medipal Holdings and its competitors. This is 10% above median its historical median of 0.31. Over the past decade, Medipal Holdings' Equity-to-Asset has ranged from 0.29 to 0.34. According to the industry distribution chart, Medipal Holdings ranks #74 out of 120 companies in the Medical Distribution industry, placing it in the top 61.7%.
Is Medipal Holdings' Equity-to-Asset too high?
Medipal Holdings' current Equity-to-Asset of 0.34 is 10% above median its 10-year median of 0.31. Over the past 10 years, this metric has ranged from a low of 0.29 to a high of 0.34. The Medical Distribution industry median Equity-to-Asset is 0.39. Medipal Holdings' value of 0.34 is 12.8% below this industry median. Based on the distribution chart, Medipal Holdings ranks #74 out of 120 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Medipal Holdings has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Equity-to-Asset compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Medipal Holdings ranks #74 out of 120 companies for Equity-to-Asset. This places Medipal Holdings in the lower half of its industry. The industry median Equity-to-Asset is 0.39. Medipal Holdings' value of 0.34 is 12.8% below this benchmark. Historically, Medipal Holdings' own Equity-to-Asset has ranged from 0.29 to 0.34 over the past decade. While the company's 10-year median is 0.31 vs. the industry median of 0.39, Medipal Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Distribution company?
The median Equity-to-Asset among Medical Distribution companies is 0.39, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medipal Holdings's current Equity-to-Asset of 0.34 is 12.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Medipal Holdings and its competitors. For the Medical Distribution industry, the median Equity-to-Asset is 0.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medipal Holdings's current Equity-to-Asset is 0.34, which is 10% above median its own 10-year median of 0.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (MEPDF) is currently considered Fairly Valued. The stock's GF Value™ is $17.73, compared to a current price of $18.35 — trading 3.5% above its estimated fair value. The current Equity-to-Asset is 0.34, which is 10% above median its 10-year median of 0.31 and 12.8% below the Medical Distribution industry median of 0.39. Medipal Holdings' overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Medipal Holdings (MEPDF), the current Equity-to-Asset is 0.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medipal Holdings (MEPDF) Overvalued in 2026?
Based on GuruFocus' analysis, Medipal Holdings stock appears to be overvalued.
The current stock price of $18.35 is trading 3.5% above its estimated GF Value™ of $17.73.
GuruFocus considers Medipal Holdings to be Fairly Valued.
Key valuation signals for MEPDF:
Equity-to-Asset: 0.34 (10% above median its 10-year median of 0.31)
GF Value™: $17.73 vs. price of $18.35 (3.5% above fair value)
Industry Position: 12.8% below the Medical Distribution median (#74 of 120)
No single metric tells the full story. See the MEPDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
81GF Score
Get the complete analysis for MEPDF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEPDF has been successfully added to your 
